Empirical Use of Antibiotics

Pediatric Guidelines



Introduction:

Antimicrobial resistance is declared a global threat to health, based on rapidly increasing resistance rates and declining new drug development. 



The majority of pediatric patients Emergency Department and inpatients wards receive antimicrobials, however it may not be necessary. 

Overprescribing increases the cost of healthcare and lead to emergence of resistant bacteria, super infection with opportunistic fungi as well as increase the likelihood of adverse drug reaction.



Main Concerns Regarding Abx Use:

Inappropriate choice of empiric antibiotics, 

Continuation of empiric therapy despite negative cultures in stable patients 

Lack of awareness of the accurate utilization of the susceptibility patterns to modify the initial/empirical Abx. 









BASIC, YET ESSENTIAL, GENERAL RULES:



Obtain cultures prior to starting/ modifying antibiotics



Once the culture/sensitivity result is ready: TAILOR your Abx to a narrow spectrum / specific therapy 



If serum trough level of the Abx is indicated ( ie Vancomycin, Gentamicin)

It should be done before the FOURTH dose.

Do not postpone the administration of the subsequent doses of the Abx UNLESS the renal function is abnormal.

If the renal function is abnormal then Do not administer the abx till ensuring a safe trough level (ie. follow the result)

If the renal function is normal then administer the Abx without delay (ie. Do not wait for th result) 



The term “Febrile Neutropenia” applies to oncology patients. 

Healthy children may have transient neutropenia during viral illness, yet only symptomatic Rx is needed (antiviral may be needed in certain cases).
Such patient should neither be labeled as “Febrile Neutropenic”, nor been isolated or kept on Abx. 

Normal response of elevated WBC and neutrophils is expected in such patients in case of secondary bacterial infection.


SKIN & S0FT TISSUE INFECTIONS



indications 

Suspected Pathogen 

Antimicrobial of choice

Alternative / comments

Non-Purulent cellulitis 

GAS

S. aureus

Augmentin

25 mg/kg/dose PO q12h



Purulent Cellulitis 



Or Abscesses including

Folliculitis, Furuncles,

carbuncles



S. aureus

(including MRSA)



Incision and drainage (I&D)



AND ( if indicated):

Clindamycin 

10 mg/ kg/ dose PO/IV q8h



I&D is the main treatment.

Use Antibiotics only if:

Substantial surrounding cellulitis

Abscess >2 cm in diameter;
 (>1cm in infants and young children)

inability to adequately drain the abscess

presence of signs or symptoms of systemic illness (i.e. fever >38' C)

immunodeficiency

Multiple sites

Necrotizing Fasciitis



GAS

S. aureus

E. coli

Pseudomonas spp.

Enterobacter spp.

Klebsiella spp.

Proteus spp.

Eacteroides spp.

Clostridia spp.

Peptostreptococcus spp.

Cefepime 

50 mg/ kg/ dose q8hr

+

Vancomycin 

15 mg/ kg/ dose lV q6h

+

Clindamycin 

10 mg/ kg/ dose lV q8h

Consult  ID & pediatric/ plastic surgery for all cases

Periorbital cellulitis (pre-septal cellulitis)



S. Pneumo 

S. aureus

GAS



Clindamycin 

10 mg/ kg/ dose PO/IV q8h

 

Orbital cellulitis

S. Pneumo

Moraxella

GAS

anaerobes

Clindamycin 

10 mg/ kg/ dose PO/IV q8h

+

Ceftriaxone 

50 mg/ kg/ dose lV q12h

lf patient colonized with MRSA

Consult lD

impetigo/ 

Folliculitis



S. aureus

GAS

Augmenting 

25 mg/ kg/ dose PO BID

AND

Mupirocin 2% topical oint. BID

lf patient colonized with MRSA

Consult lD

Cervical lymphadenitis

S. aureus

GAS

Augmenting 

25 mg/ kg/ dose PO BID



Clindamycin 

10 mg/ kg/ dose PO/IV q8h

Bites (cats, dogs

or human)

Cat/dog

Pastorella Multocida 

S. aureus 

MRSA 

streptococcus Spp

anaerobes

Human

Eikenella

s. aureus 

MRSA,

streptococcus Spp

anaerobes



Augmentin 

25 mg/ kg/ dose PO BID



OR 



Augmentin 

30 mg/ kg /dose IV q 8 hrs.











Ear & Sinus Infections

indications

Suspected Pathogen

Antimicrobial of choice

Alternative/ comments

Otitis media

Pneumococcus,

H. Influenzae non type b,

Moraxella



No previous Abx:  

Amoxicillin

90 mg/ kg/ dose q8h 

Or

Cefuroxime



Recurrent:

Augmentin



severe/ unresponsive to PO Cefotaxime



Acute mastoiditis

Pneumococcus

S. aureus 

CA-MRSA, 

GAS

Pseudomonas

Clindamycin

10 mg/ kg/ dose lV/PO q8h

+

Ceftriaxone

50 mg/ kg/ dose lV q12h

Rule out meningitis.

Surgical intervention as needed

Acute sinusitis 



1st line Amoxicillin

2nd line Augmentin

Treat with Abx only if not resolving after 7/10 of symptomatic treatment







Oropharyngeal Infections

indications 

Suspected pathogen 

Antimicrobial of choice 

Alternative / comments

Pharyngitis

GAS

Amoxicillin

45 mg/ kg/ day PO q8hr 

for 10 days

OR 

Cefuroxime PO

For penicillin allergy patients, use Azithromycin 

10 mg/ kg /day 

for 5 days

Peritonsillar abscess



Aerobic/Anaerobic flora

Ca-MRSA

Clindamycin 

10 mg/ kg /dose lV/Po q8h 

+ 

Ceftriaxone 

50 mg/ kg/ dose Q 12hrs



Retropharyngeal abscess



Aerobic/Anaerobic flora

Ca-MRSA

Clindamycin 

10 mg/ kg/ dose lV/Po q8h 

+ 

Ceftriaxone 

50 mg/ kg/ dose Q 12hrs



Tracheitis

GAS , 

S. aureus 

MRSA , pneumococcus

Pseudomonas

Ceftriaxone

50 mg/ kg/ dose lV q12h

+

Vancomycin 

15 mg /kg /dose lV q6h



GASTROINTESTINAL SYSTEM

indications 

Suspected Pathogen 

Antimicrobial of choice

Alternative / comments

Enterocolitis

Neonates (NEC)



Enteric GNR

Enterococcus

anaerobes

IV Ampicillin

+

Gentamycin

+-

Metronidazole

in severely ill patients consider: 

Vancomycin

+

Meropenem

C. Difficile- Associated Enterocolitis 





C. Diffecile

Metronidazole 

10mg/ kg/ dose PO/IV q8h

Stop offending antibiotic if possible.

Consult ID if fulminant 

or recurrent 

Peritonitis Primary

S. Pneumo 

GNR

Ceftriaxone 

50 mg/ kg/ dose lV q12h



Peritonitis secondary 

(i.e., post perforation)



GNR

anaerobes

Ampicillin 

50 mg/ kg/ dose IV q6h

+

Gentamicin 

2.5 mg/ kg/ dose lV q8

+

Metronidazole 

10 mg/ kg/ dose q8h

Consult ID

Complicated appendicitis



Tazocin







RESPIRATORY SYSTEM

Pneumonia

indications 



Suspected Pathogen 

Antimicrobial of choice



Alternative Therapy/ comments

Neonates-



GBS,

GNR

Listeria

lV Ampicillin

+

lV Gentamicin



1-3 months



S Pneumonae

C. Trachomatous

B. Pertussis

S Aureus

H. Influenza

lV Ampicillin

+

Cefotaxime 

50 mg / kg,/ dose Q8hr



Obtain a NPA for respiratory viruses

3 months - 12 years

(Immunized, CA)



S. Pneumonae

Mycoplasma

S. Aureus

Augmentin 

25 mg/ kg/ dose q12 hr.

or

Cefuroxime 

15 mg/ kg/ dose q12 hr.

Obtain a NPA for respiratory viruses

3year - 12 years (Atypical pneumonia)

M. Pneumonae

Azithromycin 

10 mg/ kg/ day

PO for 5 days



Complicated pneumonia





S. Pneumonae

S. Aureus

H. Influenza

S. Pyogenes

C. Pneumonae

M. Pneumonae

Ceftriaxone 

50 mg/ kg / dose lV q12h

+

Vancomycin

 15mg/ kg/ dose lV q6h

For severely ill patient consider 

Tazocin +Vancomycin

nosocomial (health care associated /

ventilator associated)

P. Aeruginosa

Enterobacter

Klebsiella

Serratia

Tazocin 

100 mg/ kg/ dose q8h

+

vancomycin 

15 mg / kg / dose q6 hr.

consider adding aminoglycoside in severe cases

Aspiration pneumonia	

anaerobes	

Augmentin 

30 mg/ kg /dose q8hr

Alternative : Clindamycin









UTI

indications 



Suspected Pathogen 



Antimicrobial of choice 



Alternative Therapy/ comments

Cystitis

E.coli

Klebsiella

Proteus

Nitrofurantoin 

5-7mg/ kg/ day PO q6 hr.

OR

Cefuroxime 

15 mg/ kg /dose PO BID



Pyelonephritis

E.coli

Klebsiella

Proteus

Pseudomonas

Ceftriaxone 

50mg/ kg/ dose lV q12h





Recurrent UTI prophylaxis (Only for grade 3 - 4 reflux)



TMP/SMX 

2 mg/ kg/ day Q 24 hr.



Nitrofurantoin 

2 mg/ kg/ dose Q24 hr.







Osteoarthritis

indications 



Suspected Pathogen 



Antimicrobial of choice



Alternative Therapy/ comments

Neonate



S. aureus

GBS

GNR

Cefotaxime

+

Cloxacillin



All age groups



S. aureus, 

S. Pneumonae



Clindamycin

10 m&/k8,/dose lV q8h

Add Ceftriaxone for non-immunized patients

Sickle cell anemia

S. aureus 

S. Pneumonae

Salmonella Spp



Clindamycin

10 mg/ kg/ dose lV q8h

+

Ceftriaxone 

50 mg/ kg/ dose lV q12h

Clindamycin

10 mg/ kg/ dose lV q8h

+

Ciprofloxacin 

10 mg/ kg/ dose lV q12h







Septicemia / Bacteremia

indications

Suspected Pathogen

Antimicrobial of choice

Alternative Therapy/ comments

Neonate 

(up to 4 weeks)

GBS

GNR

Listeria

Enterococcus

lV Ampicillin + lV Gentamycin







4 weeks - 3 months

Same as Neonates and Older Children



Ampicillin 

50 mg/kg/dose IV q6h

+

Cefotaxime

50mg/kg/dose lV q8h



>3months

(Community acquired)

s. pneumoniae,

Meningococcus

S.aureus,

H. influenza, 

E.coli



Ceftriaxone 

50 mg/ kg/ dose q12h







Add Vancomycin in severely ill patient

> 3months

And

Hospitalization > 48 hrs

(Hospital acquired)

P. aeruginosa, 

K.pneumoniae 

E. coli,

MRSA

Pipracillin-Tazobactam 

100 mg/kg/dose IV q8h

±

Vancomycin

15 mg/ kg/ dose lV q6h





Consider Aminoglycoside in

severely ill patient

Age > 3months

And

Septic Shock



S. pneumoniae,

Meningococcus

S. aureus, 

H. influenza,

E.coli

Pipracillin-Tazobactam 

100 mg/ kg/ dose IV q8h

+

Vancomycin 

15 mg/ kg/ dose lV q6h



Age > 3months 

And

Septic Shock 

And

Hospitalization >48hr

MRSA

ESBL -producers 

(P. aeruginosa, 

K. Pneumonae 

E. coli)

Meropenem 

40 mg/ kg/ dose q8h

+

Vancomycin 

15 mg/ kg/ dose lV q6h



consider aminoglycoside in

severely ill patient

Sickle Cell Disease

with Sepsis

S.pneumoniae,

H. influenza

Salmonella

Ceftriaxone 

50 mg/ kg/ dose q12h





ln severely ill patient, add lV Vancomycin





CNS

Meningitis

Check if there is indication for adding DEXAMETHASONE

Dose: 0.15 mg/kg/dose 6 hourly IV 4/7. 

Timing: Give before or within one hour of first dose of abx

Indications

Suspected Pathogen

Antimicrobial of choice

Alternative Therapy/ Comments

Neonate 

(up to 4 weeks)

GBS

GNR

L.monocytoqenes

Ampicillin lV

+

cefotaxime lV

( check neonatal doses)

4 weeks - 3 months

Same as Neonates and Older Children

Ampicillin 100mg/ kg/ dose lV q6h

+

Cefotaxime 50mg /kg/ dose lV 6h



Older Children

s. pneumonioe,

N-meningitidis,

Ceftriaxone 50 mg/ kg/ dose q12h



Add Vancomycin in critical cases 

Target Vancomycin level 15-20

check culture result to Stop vancomycin

Meningo- Encephalitis 



s. pneumoniae,

N-meningitidis,

HSV

Ceftriaxone 50 mg/ kg/ dose q12h

+

Acyclovir 20 mg/ kg/ dose lV q8hr

Ensure direct communication with the lab to receive and process PCR-meningitis panel

V-P Shunt Related

infection



CoNS 

GNR



Ceftazidime 50 mg/kg/dose lV 8h

+

Vancomycin 15 mg/kg/dose lV 6h

lf patient is severely ill, start Meropenem and consult lD 

Target Vancomycin level 15-20



Febrile Neutropenia in Immunocompromised

lndication

Suspected Pathogen

Antimicrobial of choice



Alternative Therapy/ Comments

Stable patients 



GNR



Cefepime

OR

Tazocin + Gentamicin



Unstable patients

GNR

GPC

 fungal

Meropenem

+

Gentamicin

Add vancomycin in severely ill patients









Abbreviations:



GBS: Group B Streptococcus,

GNR: Gram negative Rods/ Bacilli,

CoNS: Coagulase-negative Staphylococci



HSV: Herpes Simplex Virus





Definition of Complicated pneumonia:

Pneumonia complicated with:

Necrotizing pneumonia,

Para pneumonic effusion,

Empyema, 

Lung abscess

Pneumatocele





References:



Uptodate site

Red Book

Nelson's 

Antimicrobidl Guidelines, King Fahad Medical City